Feb. 8: Results of the phase 3 clinical trial showed that COVID patients who received the drug were half as likely to be admitted to hospital
over 10 years, a figure that is significantly less than what they had demanded, but which they appeared resigned to accepting. Premiers have requested increased funding since 2020, as health systems buckled under the strain of the pandemic.that most foreign air travellers be vaccinated against COVID-19, one of the country’s few remaining pandemic travel restrictions still in place.
after a spike in COVID-19 cases in China dulled store traffic. Luxury goods companies in China have suffered from intermittent lockdowns, but Canada Goose said Beijing’s decision to dismantle its zero-COVID policy late last year only added to the company’s headaches., the Quebec-based COVID-19 vaccine manufacturer that will be shut down by parent company Mitsubishi Chemical. Medicago’s Covifenz vaccine is plant-based and was approved by Health Canada one year ago for adults aged 18 to 64.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
HPEPH weekly COVID/flu update: COVID cases down, hospitalizations upThere was a slight drop in the number of active COVID-19 cases across Hastings and Prince Edward Counties last...
Read more »
Antiviral drug could be an effective COVID-19 treatment for high-risk patients, study showsCOVID patients who received the drug half as likely to be admitted to hospital or to visit an ER than those given a placebo, clinical trial results show
Read more »
COVID-19: OPH reports three new deaths in twice-weekly updateCOVID\u002D19 in Ottawa (Reported Tuesday, last update Friday)
Read more »
COVID-19: Three new deaths in Ottawa Public Health's twice-weekly updateCOVID\u002D19 in Ottawa (Reported Tuesday, last update Friday)
Read more »
COVID-19 update: Quebec reports four more deathsThe number of people hospitalized with COVID\u002D19 rose by 15.
Read more »
New one-and-done therapy can help curb severe COVID-19 infection: Canadian-led studyA Canadian-led study of a new potential antiviral therapy shows a single dose can help cut the risk of hospitalization and death from COVID-19.
Read more »